Low-Grade Gliomas of the Brainstem in Children

Status: draft · Last updated 2026-11-18 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • Brainstem LGG vs DIPG: focal, exophytic, enhancing, cystic, outside the pons or a long history means think LGG and consider surgery or biopsy (see caveats).
  • Tectal glioma: ETV (89% shunt-free) , then MRI surveillance. A quarter need tumor treatment; enhancement, eye-movement signs and spread beyond the tectum predict it .
  • Dorsally exophytic: remove the exophytic part only, and stop at the floor of the fourth ventricle .
  • Brainstem pilocytic: GTR matters (5-year PFS 74% vs 19%), and survival is excellent either way .
  • Biopsy is safe: 96% diagnostic, 0.6% permanent morbidity .
  • BRAF V600E: dabrafenib plus trametinib (47% vs 11% response) , which is a real alternative to risky resection .

Landmark papers

  • Pollack et al., J Neurosurg 1993: 18 dorsally exophytic brainstem gliomas. Removing the exophytic part, without chasing tumor into the brainstem, controlled most of them long term .
  • Kestle et al., J Neurosurg 2004: brainstem pilocytic astrocytoma. 5-year PFS 74% after GTR vs 19% with solid residual tumor, and all patients were alive .
  • Bouffet et al., N Engl J Med 2023: dabrafenib plus trametinib vs chemotherapy for BRAF V600 pediatric LGG, with a 47% vs 11% response .

Most pediatric brainstem tumors are diffuse intrinsic pontine gliomas (DIPG) , a subset of diffuse midline glioma that is fatal and not resectable. The rest are focal low-grade gliomas, which have an excellent prognosis and are often surgical. Telling the two apart on MRI is the first job (see DIPG and diffuse midline glioma).

Brainstem LGGs are usually pilocytic astrocytomas or gangliogliomas. The most common molecular change is the KIAA1549–BRAF fusion, followed by BRAF V600E and FGFR alterations .

Jason S. Hauptman, MD, PhD© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure from Hauptman's High Yield Thoughts in Pediatric Neurosurgery (pedsneurosurg.org). Do not copy, reproduce, redistribute or adapt without written permission.https://www.pedsneurosurg.org/hy-peds-ns:brainstem_lgg:4a018c107ab9ee53© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure; please do not copy, reproduce or redistribute without written permission.Midsagittal brainstem views of a tectal glioma compressing the aqueduct with hydrocephalus and an ETV opening, a focal pontine tumor, a dorsally exophytic tumor growing into the fourth ventricle and a cervicomedullary tumor at the obex, with a DIPG inset showing diffuse pontine expansion engulfing the basilar arteryBRAINSTEM LOW-GRADE GLIOMA PATTERNS (MIDSAGITTAL, ANTERIOR LEFT)(a) tectal gliomaaqueduct compressedETV openinghydrocephalus(b) focal, well circumscribedfocal pontine tumor(c) dorsally exophyticinto the fourth ventricle(d) cervicomedullaryexpands medulla and cordobexinset: DIPG for contrastdiffuse, ill-definedbasilar engulfedLow-grade patterns are focal orexophytic with clear margins.DIPG expands more than half ofthe pons, with ill-definedmargins, and engulfs the basilarartery.
Low-grade gliomas of the brainstem. Midsagittal view of the brainstem showing the main patterns: (a) tectal glioma compressing the cerebral aqueduct, with obstructive hydrocephalus and an ETV; (b) focal midbrain or pontine tumor, well circumscribed; (c) dorsally exophytic tumor fungating from the floor of the fourth ventricle into the ventricle; (d) cervicomedullary tumor centered at the obex, expanding the medulla and upper cord. Inset: diffuse pontine glioma (DIPG) for contrast, expanding more than half the pons with ill-defined margins. Not to scale.

Patterns that predict behavior

Classification by location and growth pattern guides the surgical plan . A surgical series of 62 children grouped tumors as:

Features that favor a low-grade tumor over DIPG (see caveats):

Tectal gliomas

Dorsally exophytic tumors

Focal intrinsic and cervicomedullary tumors

Biopsy

Targeted therapy

Related topics

References

  1. Lu VM, Jallo GI, Shimony N. Pediatric low-grade brainstem glioma: a review of current diagnosis and treatment paradigms in the molecular era. Childs Nerv Syst 2025;41(1):261. doi:10.1007/s00381-025-06924-z. PMID 40824451. verified
  2. Rady MR, Enayet AE, Refaat A, et al. Management and outcome of pediatric brainstem and cerebellar peduncular low-grade gliomas: a retrospective analysis of 62 cases. Childs Nerv Syst 2022;38(3):565–575. doi:10.1007/s00381-021-05405-3. PMID 34787716. verified
  3. Bauman MMJ, Giesken MB, Naylor RM, et al. Predicting disease progression and the need for tumor-directed treatment in tectal plate gliomas. J Neurosurg Pediatr 2023;32(3):332–342. doi:10.3171/2023.4.PEDS22485. PMID 37347621. verified
  4. Li KW, Roonprapunt C, Lawson HC, et al. Endoscopic third ventriculostomy for hydrocephalus associated with tectal gliomas. Neurosurg Focus 2005;18(6A):E2. PMID 16048288. verified
  5. Pollack IF, Hoffman HJ, Humphreys RP, Becker L. The long-term outcome after surgical treatment of dorsally exophytic brain-stem gliomas. J Neurosurg 1993;78(6):859–863. doi:10.3171/jns.1993.78.6.0859. PMID 8487066. verified
  6. Kestle J, Townsend JJ, Brockmeyer DL, Walker ML. Juvenile pilocytic astrocytoma of the brainstem in children. J Neurosurg 2004;101(1 Suppl):1–6. doi:10.3171/ped.2004.101.2.0001. PMID 16206964. verified
  7. Trezza A, de Laurentis C, Biassoni V, et al. Cervicomedullary gliomas in pediatric age: a systematic review of the literature and tertiary care center experience. Pediatr Neurosurg 2022;57(3):149–160. doi:10.1159/000524165. PMID 35306489. verified
  8. Hamisch C, Kickingereder P, Fischer M, et al. Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases. J Neurosurg Pediatr 2017;20(3):261–268. doi:10.3171/2017.2.PEDS1665. PMID 28621573. verified
  9. Bouffet E, Hansford JR, Garrè ML, et al. Dabrafenib plus trametinib in pediatric glioma with BRAF V600 mutations. N Engl J Med 2023;389(12):1108–1120. doi:10.1056/NEJMoa2303815. PMID 37733309. verified
  10. Campino GA, Shrot S, Constantini S, et al. Significant clinical and radiologic response to targeted therapy in pediatric cervicomedullary low-grade gliomas harboring the BRAFV600E mutation. Childs Nerv Syst 2025;41(1):429. doi:10.1007/s00381-025-07084-w. PMID 41423525. verified

Verification (2026-11-18):

Caveats: